IPC 7 English version A61P !A-A61P 15/18

IPC ⁷ English version

A61P-A61P01518

A61P 17/00 - A61P 43/00

SECTION A – HUMAN NECESSITIES

A 61

MEDICAL OR VETERINARY SCIENCE; HYGIENE

A 61 P

THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS [7]

Notes

(1)

This subclass covers therapeutic activity of chemical compounds or medicinal preparations already classified as such in subclasses A61K or C12N, or in classes C01, C07 or C08. [7]

(2)

In this subclass, the term "drugs" includes chemical compounds or compositions with therapeutic activity. [7]

(3)

In this subclass, therapeutic activity is classified in all appropriate places. [7]

(4)

The classification symbols of this subclass are not listed first when assigned to patent documents. [7]

Drugs for disorders of the alimentary tract or the digestive system [7]

Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis [7]

for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants [7]

Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia [7]

for nausea, cinetosis or vertigo; Antiemetics [7]

Laxatives [7]

Antidiarrhoeals [7]

Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents [7]

for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics [7]

for pancreatic disorders, e.g. pancreatic enzymes [7]

Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P 7/00) [7]

Nutrients, e.g. vitamins, minerals [7]

Anorexiants; Antiobesity agents [7]

Antihyperlipidemics [7]

for glucose homeostasis (pancreatic hormones A61P 5/48) [7]

for hyperglycaemia, e.g. antidiabetics [7]

for electrolyte homeostasis [7]

for calcium homeostasis (vitamin D A61P 3/02; parathyroid hormones A61P 5/18; calcitonin A61P 5/22; osteoporosis A61P 19/10; bone metastasis A61P 35/04) [7]

Drugs for disorders of the endocrine system [7]

of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin [7]

for decreasing, blocking or antagonising the activity of the hypothalamic hormones [7]

of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH [7]

for decreasing, blocking or antagonising the activity of the anterior pituitary hormones [7]

of the posterior pituitary hormones, e.g. oxytocin, ADH [7]

for decreasing, blocking or antagonising the activity of the posterior pituitary hormones [7]

of the thyroid hormones, e.g. T3, T4 [7]

for decreasing, blocking or antagonising the activity of the thyroid hormones [7]

of the parathyroid hormones [7]

for decreasing, blocking or antagonising the activity of PTH [7]

for decreasing, blocking or antagonising the activity of calcitonin [7]

of the sex hormones [7]

Androgens [7]

Antiandrogens [7]

Oestrogens [7]

Antioestrogens [7]

Gestagens [7]

Antigestagens [7]

of the suprarenal hormones [7]

Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids [7]

for decreasing, blocking or antagonising the activity of mineralocorticosteroids [7]

Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids [7]

for decreasing, blocking or antagonising the activity of glucocorticosteroids [7]

of the pancreatic hormones [7]

for increasing or potentiating the activity of insulin [7]

Drugs for disorders of the blood or the extracellular fluid [7]

Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors [7]

Antihaemorrhagics; Procoagulants; Haemostatatic agents; Antifibrinolytic agents [7]

Antianaemics [7]

Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P 27/04) [7]

Antioedematous agents; Diuretics [7]

Antidiuretics, e.g. drugs for diabetes insipidus (ADH A61P 5/10) [7]

Drugs for disorders of the cardiovascular system [7]

Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives [7]

Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure [7]

Antiarrhythmics [7]

Vasodilators for multiple indications [7]

for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis [7]

Antihypertensives [7]

Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers [7]

11/

Drugs for disorders of the respiratory system [7]

11/

Nasal agents, e.g. decongestants [7]

11/

for throat disorders [7]

11/

Antiasthmatics [7]

11/

Bronchodilators [7]

11/

Expectorants [7]

11/

Mucolytics [7]

11/

Antitussive agents [7]

11/

Central respiratory analeptics [7]

13/

Drugs for disorders of the urinary system (diuretics A61P 7/10) [7]

13/

of urine or of the urinary tract, e.g. urine acidifiers [7]

13/

for urolithiasis [7]

13/

Anti-spasmodics [7]

13/

of the prostate [7]

13/

of the bladder [7]

13/

of the kidneys [7]

15/

Drugs for genital or sexual disorders (for disorders of sex hormones A61P 5/24); Contraceptives [7]

15/

for disorders of the vagina [7]

15/

for inducing labour or abortion; Uterotonics [7]

15/

Antiabortive agents; Labour repressants [7]

15/

for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis [7]

15/

for impotence [7]

15/

for climacteric disorders [7]

15/

for lactation disorders, e.g. galactorrhoea [7]

15/

Masculine contraceptives [7]

15/

Feminine contraceptives [7]

A61P 17/00 - A61P 43/00